FOSTER CITY, Calif. - Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical firm with a market capitalization of $119.87 billion, announced today a 2.6% increase in its quarterly cash dividend.
If you need to generate income from your investments, selecting securities or funds based on their current interest or dividend payouts might solve the immediate problem. But a strategy of increasing ...
The stock looks like a decent value, but it could be a bargain if management can execute. Its dividend checks all the boxes ...
The S&P 500 Dividend Aristocrats Index pairs long-term results with versatility.
Nathan Eigerman: The Value Line® Index* represents a higher dividend yield core U.S. equity portfolio. Some investors are ...